Veterinary Antibiotics Market Report 2026

Veterinary Antibiotics Market Overview

• Veterinary Antibiotics market size has reached to $2.34 billion in 2025 • Expected to grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Growing Pet Ownership To Drive Market Growth • Market Trend: Digital Health And Telemedicine Reshaping The Veterinary Antibiotics Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Antibiotics Market?

Veterinary antibiotics refer to a class of animal medications that are used to treat infectious disease in animals by killing microorganisms such as bacteria and parasites by inhibiting the growth of their cell walls to fight infections and diseases in animals caused by bacteria and improve the animals' health conditions. The main product types of veterinary antibiotics include anti-parasitic, anti-bacterial, non-steroidal anti-inflammatory drugs, and other products. Non-steroidal anti-inflammatory drugs (NSAIDs) act as a bridge between the production and activity of prostaglandins (enzymes) implicated in inflammation. Approved veterinary NSAIDs are used in companion animal care to reduce the pain and swelling linked with osteoarthritis in dogs and horses. The administration of veterinary antibiotics includes premixes, injections, oral powders, oral solutions, and other administrations used on farm animals and companion animals.

What Is The Veterinary Antibiotics Market Growth Forecast?

The veterinary antibiotics market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to adoption of precision medicine in veterinary care, innovation in oral and premix formulations, regulatory support for antibiotic stewardship, increasing pet ownership and spending, integration of digital monitoring in antibiotic administration. Major trends in the forecast period include rising demand for anti-bacterial and anti-parasitic drugs, expansion of companion animal antibiotic usage, shift toward oral solutions and premixes for easy administration, increasing focus on nsaids for livestock pain management, development of multi-functional veterinary antibiotic formulations.

Global Veterinary Antibiotics Market Segmentation

1) By Product: Anti-Parasitic, Anti-Bacterial, Non-Steroidal Anti-Inflammatory Drug, Other Products 2) By Administration: Premixes, Injections, Oral Powders, Oral Solutions, Other Administrations 3) By End User: Farm Animals, Companion Animals Subsegments: 1) By Anti-Parasitic: Endoparasiticides, Ectoparasiticides 2) By Anti-Bacterial: Tetracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides 3) By Non-Steroidal Anti-Inflammatory Drug (NSAID): Carprofen, Meloxicam, Aspirin 4) By Other Products: Antifungal, Antiviral

What Is The Driver Of The Veterinary Antibiotics Market?

The rising pet ownership rate is expected to propel the growth of veterinary antibiotics market going forward. Pet ownership is the legally recognized and responsible act of having and caring for domesticated animals as companions, which involves providing for their physical, emotional, and medical needs. Pet ownership rate is rising due to increasing desire for companionship, as more individuals and families adopt pets to reduce loneliness and improve emotional well-being. Veterinary antibiotics help increase pet ownership rate by ensuring pets remain healthy and disease-free, giving owners confidence in their ability to care for them. For instance, in October 2024, according to the American Veterinary Medical Association, a US-based nonprofit professional association, the total number of dog-owning households in the U.S. is projected to increase by 59.8 million in 2024, which is 45.5%) of all U.S. households, and the number of cat-owning households has increased by 42.1 million in 2024, which is 32.1%) of all U.S. households. Therefore, the rising pet ownership rate is driving the growth of veterinary antibiotics industry.

Key Players In The Global Veterinary Antibiotics Market

Major companies operating in the veterinary antibiotics market are Boehringer Ingelheim GmbH, Zoetis, Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Dechra Pharmaceuticals plc, Bayer Animal Health China, China Animal Healthcare Ltd., China Animal Husbandry Industry Corporation Ltd. (CAHIC), Guangdong Wens Dahuanong Biotechnology Co. Ltd., Merial Pulike Biological Engineering, Ceva Santé Animale, Nimrod Veterinary Products Ltd., Bimeda, VIRBAC SA, Orion Animal Health, Laboratorios Calier, SA, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Lamons Laboratories SA, SUPER'S DIANA, Swetrade Pharmaceuticals AB, Animalcare, VIC Animal Health, AVZ animal health, Provet Group, VitOMEK LCC, Micro-plus, Biowet, Bioveta, Brovapharma, Evrovet, Ukrvetprompostach, VELELEK d.o.o, Veterinarski Zavod Subotica, VetPlanet, Delos Medica, Vetro Solutions, Belfarmacom, IDT Biologika, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Saudi Pharmaceutical Industries (SPI), DBK Pharma S.A.E.

Global Veterinary Antibiotics Market Trends and Insights

Major companies operating in the veterinary antibiotics market are developing telemedicine platforms for pet healthcare to gain a competitive edge in the market. Telemedicine is a healthcare practice that involves the remote diagnosis, consultation, treatment, and monitoring of patients using telecommunications technology, such as video conferencing, phone calls, or secure messaging platforms. For instance, in June 2023, Cargill Inc., a US-based food corporation launched Zoonivet, a digital pet-care app. This Telehealth platform simplifies pet healthcare by connecting pet parents with qualified veterinarians through video calls, making primary pet care accessible and convenient. Zoonivet also plans to provide surgery, home diagnostic services, medication, pet food, and pet boarding across key Indian markets.

What Are Latest Mergers And Acquisitions In The Veterinary Antibiotics Market?

In July 2024, Merck Animal Health, a US–based provider of veterinary pharmaceuticals, vaccines, nutritionals and health management solutions for livestock, companion animals and aquaculture, acquired Elanco Animal Health Incorporated’s aqua business for approximately $1.3 billion. With this acquisition, Merck aims to broaden its global aquaculture portfolio and strengthen its scientific and commercial capabilities across warm‑water and cold‑water products to better serve fish health, welfare and sustainability needs. Elanco Animal Health Incorporated is a US-based provider of aquaculture‑focused health solutions, including vaccines, anti‑parasitic treatments, water supplements and nutrition products for aquatic species, along with related manufacturing and research operations.

Regional Outlook

North America was the largest region in the veterinary antibiotics market in 2025. Asia-Pacific was the second-largest region in the global veterinary antibiotics market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Antibiotics Market?

The veterinary antibiotics market consists of sales of antivirals, antiprotozoals, antifungals, aminoglycosides, beta-lactams, fluoroquinolones, glycopeptides, and lipopeptides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.